Five notes from the report:
1. Net sales were $270.8 million, down 8.3 percent from $295.3 million in the same time last year. They were driven by new product introductions in the spine portfolio and the company’s international performance.
2. The company’s cervical portfolio saw double-digit year-over-year growth in the U.S., led by the Simplify cervical disc.
3. GAAP net loss was $21.6 million. The company’s third-quarter net income in 2020 was $5.9 million.
4. As of Sept. 30, cash, cash equivalents and investments were $234.6 million.
5. CEO J. Christopher Barry said in a news release, “The third quarter presented unexpected challenges for elective surgical procedures due to the negative impact from the resurgence of COVID-19 and healthcare staffing shortages. Despite these external factors, our strategy remains unchanged.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
